Skip to content

Exagen Inc. XGN Debt Repayments

Debt Repayments at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$0-100%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1M-99.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$100K0.0%
Revvity logo
RevvityRVTY
$0+100%
Agilent Technologies logo
Agilent TechnologiesA
$1M
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$5K-28.6%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s debt repayments?
Exagen Inc. (XGN) reported debt repayments of $168K in Q1 2026.
How has Exagen Inc.'s debt repayments changed year-over-year?
Exagen Inc.'s debt repayments increased by 57.0% year-over-year, from $107K to $168K.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.